Fabry Disease: An Update Based on Evidence and Experience
Abstract Fabry disease is an X-linked genetic disorder caused by GLA gene variants, resulting in a lysosomal enzyme deficiency of the acid hydrolase α-galactosidase A, with a progressive accumulation of globotriaosylceramide that mainly affects the cardiovascular, renal, and nervous systems. In Sept...
Saved in:
| Main Authors: | J. Politei, F. Perretta, H. Trimarchi, N. Antongiovanni, G. Cabrera, A. Fainboim, A. Fernández, F. Gómez Pizarro, M. Pereyra, S. Jaurretche |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SciELO
2025-06-01
|
| Series: | Journal of Inborn Errors of Metabolism and Screening |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942025000100402&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fabry Cardiomyopathy: Myocardial Fibrosis, Inflammation, and Down‐Regulation of Mannose‐6‐Phosphate Receptors Cause Low Accessibility to Enzyme Replacement Therapy
by: Andrea Frustaci, et al.
Published: (2025-02-01) -
Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry disease
by: Malte Lenders, et al.
Published: (2025-02-01) -
Expert review in diagnostic, therapeutic and follow-up of Fabry disease in Latin America based on patient care standards
by: Roberto Giugliani, et al.
Published: (2025-06-01) -
Assessing osteopenia and osteoporosis with dual-energy x-ray absorptiometry studies in Fabry disease
by: Alyaa Shmara, et al.
Published: (2025-04-01) -
Fabry disease phenotyping in women from the complete Romanian cohort – time for early diagnostic awareness
by: Mursă Adriana, et al.
Published: (2024-12-01)